Evidence map›Paper›PMID 41160607›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Metabolic adaptation of glucose-deprived macrophages involves partial gluconeogenesis.

Katharina Schindlmaier, Theresa Haitzmann, Visnja Bubalo, Barbara Konrad, Joseph Jelwan, Gabriele Bluemel, Sonja Rittchen, Vanessa Jäger, Michael A Dengler, Luka Brcic and 8 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Infection and immunity · 2026
    Article
  3. Article
  4. Review
  5. bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Katharina SchindlmaierDivision of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz 8010, Austria.ORCID 0000-0002-6703-5123
Theresa HaitzmannDivision of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz 8010, Austria.
Visnja BubaloDivision of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz 8036, Austria.ORCID 0009-0005-5374-7487
Barbara KonradDivision of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz 8036, Austria.ORCID 0009-0008-4521-202X
Joseph JelwanDivision of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz 8010, Austria.ORCID 0009-0002-2533-4456
Gabriele BluemelDepartment of Biosciences and Medical Biology, Bioanalytical Research Labs, University of Salzburg, Salzburg 5020, Austria.
Sonja RittchenDivision of Immunology, Otto Loewi Research Center, Medical University of Graz, Graz 8010, Austria.ORCID 0000-0002-8753-4384
Vanessa JägerDivision of Oncology, Department of Internal Medicine, Medical University of Graz, Graz 8036, Austria.
Michael A DenglerDivision of Oncology, Department of Internal Medicine, Medical University of Graz, Graz 8036, Austria.ORCID 0000-0002-1693-1761
Luka BrcicDiagnostic and Research Institute of Pathology, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, Graz 8010, Austria.ORCID 0000-0002-9098-8416
Jörg LindenmannLung Research Cluster, Medical University of Graz, Graz 8010, Austria.
Leigh M MarshLung Research Cluster, Medical University of Graz, Graz 8010, Austria.ORCID 0000-0002-1754-9249
Thomas O EichmannCore Facility Mass Spectrometry, Medical University of Graz, Graz 8010, Austria.ORCID 0000-0002-8521-2795
Alexander KirchmairBiocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck 6020, Austria.ORCID 0000-0003-2284-7424
Zlatko TrajanoskiBiocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck 6020, Austria.
Julia KarglDivision of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz 8010, Austria.
Cristina Muñoz-PinedoPreclinical and Experimental Research in Thoracic Tumors, Bellvitge Biomedical Research Institute, L'Hospitalet 08908, Spain.ORCID 0000-0002-9120-664X
Katharina LeithnerDivision of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz 8010, Austria.ORCID 0000-0002-8252-9279

Funding

Austrian Federal Ministry for Education, Science and Research MMC-2023-07001Austrian Science Fund (FWF) 884-BAustrian Science Fund (FWF) DOC129Austrian Science Fund (FWF) P33508Austrian Science Fund (FWF) P35294EC | European Innovation Council and Small and Medium-sized Enterprises Executive Agency (EISMEA) INCITE 964955EC | European Research Council (ERC) EPIC 786295European Molecular Biology Organization (EMBO) 10661
6 · The paper itself

Abstract

Macrophages are recruited to sites of infection contributing to the killing of bacteria, but also to malignant tumors, where they promote angiogenesis and suppress antitumor immune responses. The metabolic microenvironment in tumors is frequently depleted of important nutrients such as glucose. Here, we investigated metabolic adaptation strategies of macrophages to glucose deprivation using stable isotopic tracing. Lactate production was decreased, potentially indicating a reduction of glycolysis. In contrast, the contribution of glutamine to the tricarboxylic acid cycle via α-ketoglutarate and reductive carboxylation were increased. Moreover, gluconeogenesis, the reverse pathway of glycolysis, was activated in glucose-deprived macrophages, proceeding partially to the generation of glycolytic intermediates and glycerol-3-phosphate. The partial gluconeogenesis pathway was abrogated in human and murine macrophages lacking the initial gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PCK2, mitochondrial isoform). Partial gluconeogenesis was higher in anti-inflammatory, interleukin-4-stimulated compared to proinflammatory, interferon-γ/lipopolysaccharide-stimulated macrophages. Single-cell analysis and immunostaining revealed expression of PCK2 in macrophages from both lung cancer and normal lung. Low glucose conditions only partially modulated macrophage phenotypes, leading to reduced CD80 surface marker levels in proinflammatory, and enhanced vascular endothelial growth factor expression in anti-inflammatory macrophages. Our study reveals partial gluconeogenesis in glucose-deprived macrophages and shows that this versatile type of immune cells exhibits remarkable metabolic flexibility.

Indexed as

Adaptation, PhysiologicalGluconeogenesisGlucoseMacrophagesAnimalsGlycolysisHumansMicePhosphoenolpyruvate Carboxykinase (ATP)Phosphoenolpyruvate Carboxykinase (GTP)GlucosePCK2 protein, humanPhosphoenolpyruvate Carboxykinase (ATP)Phosphoenolpyruvate Carboxykinase (GTP)glucose deprivationglycolysismacrophagesmetabolismpartial gluconeogenesis

Identifiers

PMID41160607
PMCPMC12595420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.